Cargando…

HMGB1 is an early mediator of inflammation and may be negatively regulated by soluble receptor for advanced glycation end products in experimental endotoxinemia and in sepsis

Detalles Bibliográficos
Autores principales:	Sunden-Cullberg, Jonas, Soop, Anne, Tokics, Leif, Treutiger, Carl-Johan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300636/ http://dx.doi.org/10.1186/cc7077

Ejemplares similares

Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock
por: Linder, Adam, et al.
Publicado: (2012)

Short- and Long-Term Mortality in Severe Sepsis/Septic Shock in a Setting with Low Antibiotic Resistance: A Prospective Observational Study in a Swedish University Hospital
por: Linnér, Anna, et al.
Publicado: (2013)

Resistin in severe bacterial infections
por: Johansson, Linda, et al.
Publicado: (2007)

Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality
por: Lange, Anna, et al.
Publicado: (2017)

Whole blood impedance aggregometry findings in experimental endotoxinemia
por: Simm, Vivian, et al.
Publicado: (2013)

Prognostic significance of body temperature in the emergency department vs the ICU in Patients with severe sepsis or septic shock: A nationwide cohort study
por: Inghammar, Malin, et al.
Publicado: (2020)

Sex-based differences in ED management of critically ill patients with sepsis: a nationwide cohort study
por: Sunden-Cullberg, Jonas, et al.
Publicado: (2020)

Systemic endotoxinemia as a probable factor in reducing the treatment effectiveness of endogenous psychosis
por: Zozulya, S., et al.
Publicado: (2021)

Plasma calprotectin as an indicator of need of transfer to intensive care in patients with suspected sepsis at the emergency department
por: Parke, Åsa, et al.
Publicado: (2023)

Correlation of clinical sepsis definitions with microbiological characteristics in patients admitted through a sepsis alert system; a prospective cohort study
por: Yu, David, et al.
Publicado: (2022)

Risk assessment in sepsis: a new prognostication rule by APACHE II score and serum soluble urokinase plasminogen activator receptor
por: Giamarellos-Bourboulis, Evangelos J, et al.
Publicado: (2012)

Systemic, but not local, low-grade endotoxinemia increases plasma sCD163 independently of the cortisol response
por: Bach, Ermina, et al.
Publicado: (2019)

HMGB1 in severe soft tissue infections caused by Streptococcus pyogenes
por: Johansson, Linda, et al.
Publicado: (2014)

HMGB1 expression in streptococcal soft-tissue infections correlates with disease severity
por: Sendi, Parham, et al.
Publicado: (2007)

Single-Sampling Strategy vs. Multi-Sampling Strategy for Blood Cultures in Sepsis: A Prospective Non-inferiority Study
por: Yu, David, et al.
Publicado: (2020)

Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control
por: Pullerits, Rille, et al.
Publicado: (2005)

Soluble receptor for advanced glycation end-products and progression of airway disease
por: Iwamoto, Hiroshi, et al.
Publicado: (2014)

Serum levels of high mobility group box‐1 protein (HMGB1) and soluble receptors of advanced glycation end‐products (RAGE) in depressed patients treated with electroconvulsive therapy
por: Abe, Hiromi, et al.
Publicado: (2023)

HMGB1 is a critical molecule in the pathogenesis of Gram-negative sepsis()
por: Andersson, Ulf, et al.
Publicado: (2022)

Plasma advanced glycation end products and soluble receptor for advanced glycation end products as indicators of sterol content in human carotid atherosclerotic plaques
por: Pinto, Raphael S, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Soluble receptor for advanced glycation end products as an indicator of pulmonary vascular injury after cardiac surgery
por: Tuinman, Pieter R, et al.
Publicado: (2013)

Plasma concentrations of secretory leukocyte protease inhibitor (SLPI) differ depending on etiology and severity in community-onset bloodstream infection
por: Lange, Anna, et al.
Publicado: (2019)

Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
por: Jensen, Louise J. N., et al.
Publicado: (2015)

Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
por: Liu, Heliang, et al.
Publicado: (2020)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
por: Pratte, Katherine A., et al.
Publicado: (2021)

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

HMGB1 redox during sepsis
por: Abdulmahdi, Wasan, et al.
Publicado: (2017)

Serum Adiponectin, Resistin, and Circulating Soluble Receptor for Advanced Glycation End Products in Colectomy Patients
por: Asgeirsson, Theodor, et al.
Publicado: (2011)

Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus
por: Škrha, J., et al.
Publicado: (2013)

Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014)

The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype
por: Miłkowska-Dymanowska, Joanna, et al.
Publicado: (2018)

The Relationship between Plasma Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease
por: Wang, Xiangming, et al.
Publicado: (2019)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Soluble Receptor for Glycation End-products Concentration Increases Following the Treatment of Severe Diabetic Ketoacidosis
por: Hoffman, William H., et al.
Publicado: (2020)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
por: Wu, Shou-En, et al.
Publicado: (2021)

Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products
por: Zhang, Hui, et al.
Publicado: (2021)

Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
por: Takata, Takanobu, et al.
Publicado: (2019)

Advanced Glycation End-Product Precursor Methylglyoxal May Lead to Development of Alzheimer’s Disease
por: Li, Wai Yin, et al.
Publicado: (2022)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
por: Assiri, Adel M. A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k15ii6c9jbamvf5krgfkfgupev